Sector ratings Luye Pharma Group Ltd.

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:15 17/09/2024 BST			5-day change	1st Jan Change
2.960 ^HKD	+0.34%		0.00%	-20.64%

08-30	Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4	MT
08-28	Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	ESG Refinitiv	Capi. ($)
LUYE PHARMA GROUP LTD.	B-	1.43B
ELI LILLY AND COMPANY	C+	816B
NOVO NORDISK A/S	B	597B
JOHNSON & JOHNSON	C+	402B
ABBVIE INC.	C+	342B
MERCK & CO., INC.	B-	300B
ROCHE HOLDING AG	A+	253B
ASTRAZENECA PLC	B+	244B
NOVARTIS AG	B-	234B
AMGEN INC.	C+	179B
PFIZER, INC.	C+	169B
SANOFI	B+	143B
GILEAD SCIENCES, INC.	B-	103B
BRISTOL-MYERS SQUIBB COMPANY	B	100B
GSK PLC	B	86.44B
CHUGAI PHARMACEUTICAL CO., LTD	A-	79.73B
DAIICHI SANKYO CO., LTD.	A-	66.63B
HALEON PLC	B	47.67B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	B+	47.07B
Average	B	221.68B
Weighted average by Cap.	B